April 16, 2008 - Pelikan Technologies Inc., a leading developer of innovative hand-held diagnostic and monitoring devices, and Eli Lilly and Company announced the signing of a three-year co-promotion agreement.Under the terms of the co-promotion agreement, the companies will promote awareness and education in the management and treatment of diabetes, including insulin therapy, insulin delivery devices and technological advancements in lancing designed to optimize Finger Health and Glucose Monitoring... [PDF] Pelikan Technologies' Press Release -
